Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control

(2010) Joost H.C.M. Kreijtz et al.   Human vaccines & immunotherapeutics

Of Ferrets and Humans: Influenza Pathogenesis

(2010) Richard J. Whitley   JOURNAL OF INFECTIOUS DISEASES

Severity of Pneumonia Due to New H1N1 Influenza Virus in Ferrets Is Intermediate between That Due to Seasonal H1N1 Virus and Highly Pathogenic Avian Influenza H5N1 Virus

(2010) Judith M. A. van den Brand et al.   JOURNAL OF INFECTIOUS DISEASES

Assessment of the Efficacy of Commercially Available and Candidate Vaccines against a Pandemic H1N1 2009 Virus

(2010) Gary P. Kobinger et al.   JOURNAL OF INFECTIOUS DISEASES

Report of the fourth meeting on ‘Influenza vaccines that induce broad spectrum and long-lasting immune responses’, World Health Organization and Wellcome Trust, London, United Kingdom, 9–10 November 2009

(2010) Iain Stephenson et al.   VACCINE

An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination

(2010) Falko Schmeisser et al.   VACCINE

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara

(2009) Guus F Rimmelzwaan et al.   Expert Review of Vaccines

Animal models for the preclinical evaluation of candidate influenza vaccines

(2009) Rogier Bodewes et al.   Expert Review of Vaccines

Modified Vaccinia Virus Ankara Triggers Chemotaxis of Monocytes and Early Respiratory Immigration of Leukocytes by Induction of CCL2 Expression

(2009) M. H. Lehmann et al.   JOURNAL OF VIROLOGY

MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization

(2009) Joost H. C. M. Kreijtz et al.   PLoS One

Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets

(2009) Vincent J. Munster et al.   SCIENCE

Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza

(2009) Nicolas Collin et al.   VACCINE

Recombinant Modified Vaccinia Virus Ankara Expressing the Hemagglutinin Gene Confers Protection against Homologous and Heterologous H5N1 Influenza Virus Infections in Macaques

(2008) J. H. C. M. Kreijtz et al.   JOURNAL OF INFECTIOUS DISEASES